Emily Sohn is a freelance journalist in Minneapolis. She writes mainly about health, science, adventure and complex conservation questions. Her stories have appeared in Nature, the Washington Post, NPR, Aeon, bioGraphic and many other publications. See more at www.tidepoolsinc.com.
Emily Sohn
Contributing writer
From this contributor
Maiken Nedergaard’s power of disruption
The award-winning researcher’s discoveries have changed the way we think about the brain; that’s exactly what her critics dislike.
Maiken Nedergaard’s power of disruption
By
Emily Sohn
26 February 2024 | 24 min read
Rising star: Ann Kennedy bridges gap between biology, computational theory
A theoretical neuroscientist, Kennedy uses a blend of computational modeling and real-world experiments to understand how brain activity shapes the behaviors of animals that model autism and other conditions.
Rising star: Ann Kennedy bridges gap between biology, computational theory
By
Emily Sohn
26 July 2022 | 14 min read
Low standards corrode quality of popular autism therapy
Rapid growth and inadequate standards in the 'applied behavior analysis' industry may put vulnerable children in the hands of poorly prepared technicians.
Low standards corrode quality of popular autism therapy
By
Emily Sohn
28 October 2020 | 18 min read
The blurred line between autism and intellectual disability
Doctors often conflate autism and intellectual disability, and no wonder: The biological distinction between them is murky. Scientific progress depends on knowing where the conditions intersect — and part ways.
The blurred line between autism and intellectual disability
By
Emily Sohn
15 April 2020 | 15 min read
How abuse mars the lives of autistic people
Many people with autism experience a triad of trauma: neglect at home, abuse from trusted adults and bullying at school or work.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read